— Know what they know.
Not Investment Advice

019175.KS KSC

Shinpoong Pharmaceutical Co.,Ltd
1W: +1.7% 1M: -10.3% 3M: +5.5% YTD: -29.9% 1Y: -44.1% 3Y: -47.7% 5Y: -89.7%
₩14,080.00 ($10.48)
-70.00 (-0.49%)
 
Weekly Expected Move ±5.5%
₩12518 ₩13299 ₩14080 ₩14861 ₩15642
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 51 · ₩373.1B mcap · 18M float · 0.028% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap₩373.1B ($277.8M)
52W Range7570-28500
Volume133
Avg Volume5,094
Beta1.12
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJei-Man Ryu
Employees815
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2005-09-29
161, Yeoksam-ro
Seoul, GY 06246
KR
82 2 2189 3400
About Shinpoong Pharmaceutical Co.,Ltd

Shinpoong Pharmaceutical Co., Ltd., a South Korean firm, specializes in the production and distribution of a broad spectrum of pharmaceutical goods. Its product offerings span various therapeutic categories, including cephalosporin and penicillin antibiotics, as well as a range of finished drug formulations. The company further supplies active pharmaceutical ingredients (APIs) and specialized medications like Pyramax, an anti-malarial treatment. Additionally, Shinpoong develops drugs for conditions such as hypercholesterolemia, knee osteoarthritis, shoulder periarthritis, and for preventing surgical adhesion, alongside its over-the-counter (OTC) products. With a notable international footprint, Shinpoong Pharmaceutical exports its remedies to approximately 50 countries globally. This company, established in 1962, is headquartered in Seoul, South Korea.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms